Nicholas Vardy
The Rise and Fall of Emerging Markets
Looking back, the decade between 2000 and 2009 marked the glory years for emerging markets.
Hold onto the November $110 Calls for Pharmaceutical Company
Please hold onto your November $110 call options (GILD141122C00110000) in Gilead (GILD), which we recommended in last Monday’s alert. Today’s alert mentioned selling November $100 Gilead call options, but we do not own those options. I will watch the November $110 call options closely for a good time to exit. We apologize for any confusion.
Lock in 53.57% Gains in Pharmaceutical Options in Just Five Days
It was a down week for U.S. markets, as the Dow Jones fell 0.87% and the S&P 500 tumbled 1.10%. The NASDAQ held up the best and was down only 0.33%. The MCSI Emerging Markets Index endured a massive drop, plummeting 4.49%. There were not big gainers in your Bull Market Alert portfolio this week, […]
![[Alibaba Logo]](https://stage8.stockinvestor.com/wp-content/uploads/3365989893_ef5f7355ca_b.jpg)
Can the Alibaba IPO Kick-start the Chinese Stock Market?
The renewed focus on Chinese Internet stocks — thanks to the upcoming listing of Chinese e-commerce giant Alibaba — could make Chinese Internet stocks one of the hottest sectors in the coming months.
On the Rebound with Gilead Sciences
It was a mostly flat week for the holiday-shortened week, as the Dow Jones rose 0.23%, the S&P 500 was up 0.22% and the NASDAQ eked out a 0.06% gain. Global markets fared much better with the MCSI Emerging Markets Index jumping 1.75%. Big gainers in your Bull Market Alert portfolio included The Bank of […]
Markets Pause for Breath ahead of September
It was a mixed week for global stock markets. Markets struggled to consolidate their recent strong gains, even as the S&P 500 breached and briefly held the 2,000 level for the first time. The Dow Jones ended the week down 0.20%, the S&P 500 rose 0.14% and the NASDAQ eked out a 0.57% gain. Reflecting […]